Clinical Trial Update: Corticosteroid Nasal Spray in COVID-19 Anosmia [Phase 3]

View source ↗

Summary

Phase 3 trial update on a corticosteroid nasal spray for COVID-19-related anosmia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia

Snippet

Sponsor: Benha University | Conditions: Covid19, Anosmia | Phase 3 | Status: COMPLETED